• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Sanofi

Sanofi
Pharma

Sanofi moves on J&J's Darzalex in first-line myeloma with FDA nod

The FDA approved Sanofi's Sarclisa to be used with a popular treatment regimen in certain patients with previously untreated multiple myeloma.
Angus Liu Sep 20, 2024 4:06pm
Beyfortus

Sanofi, AZ look to avoid Beyfortus shortfalls this year

Sep 17, 2024 11:33am
Lilly

Lilly secures FDA nod for atopic dermatitis therapy Ebglyss

Sep 16, 2024 11:16am
Sanofi

Sanofi completes build out of $554M pandemic-ready modular plant

Sep 12, 2024 10:21am
winnter trophy star

Meet the winners of the 2024 Fierce Pharma Marketing Awards

Sep 12, 2024 9:00am
FDA

Sanofi, Regeneron build case for Dupixent in bullous pemphigoid

Sep 11, 2024 10:56am

Home
  • Connect
    • The Team
    • Advertise
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2024 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings